What We're Reading: Page 105
Industry reads hand-picked by our editors
May 10, 2022
-
TCTMD
KardiaBand More Accurate Than Apple Watch 4 in Diagnosing AF
-
NPR
How period tracking apps and data privacy fit into a post-Roe v. Wade climate
-
Healthcare Dive
Telehealth use fell in February as omicron retreated
-
The Washington Post
People who never get the coronavirus could teach us more about coronavirus
May 09, 2022
-
Business Insider
The DOJ Is Investigating Mental-Health Startup Cerebral
-
Medtech Insight
Digital Health: FDA’s Shuren Predicts ‘Critical Regulatory Hurdles’ If Congress Doesn’t Update Reg Frameworks
-
The New York Times
A Nationwide Baby Formula Shortage Is Getting Worse
-
Kaiser Health News
A Guide to Help You Keep Up With the Omicron Subvariants
May 06, 2022
-
BioPharma Dive
FDA places stricter limits on J&J's COVID-19 vaccine after review of rare side effect
-
MobiHealthNews
MedRhythms partners with Biogen to develop, commercialize mobility PDT
-
STAT News
White House documents detail a looming squeeze on Covid-19 boosters
-
Medical Design & Outsourcing
Fresenius Medical Care hires Carla Kriwet to replace CEO Rice Powell
May 05, 2022
May 04, 2022
-
MobiHealthNews
At-home diagnostics company LetsGetChecked wraps up BioIQ acquisition
-
The New York Times
New York City Enters Higher Coronavirus Risk Level as Case Numbers Rise
-
STAT News
New analysis finds inconsistencies in how FDA uses expert panels
-
MedCity News
How AI is helping to address staffing shortages in healthcare
May 03, 2022
-
STAT News
Guardant Health launches early-detection test for colon cancer
-
Bloomberg
EU Ready to Spend $2.6 Billion on Hub for Health-Care Data
-
Fierce Biotech
FDA crowns Johnson & Johnson's Monarch surgical robot with urology nod
-
Kaiser Health News
At US Hospitals, a Drug Mix-Up Is Just a Few Keystrokes Away
May 02, 2022
-
The Washington Post
Coronavirus mutations aren't slowing down
-
Medical Design & Outsourcing
Johnson & Johnson shareholders approve racial justice audit proposal
-
MobiHealthNews
Mobile app-based health studies hampered by low participant engagement, retention rates
-
Medtech Insight
Study: FDA Data Shows Endoscope-Related Adverse Events Continue To Rise
Previous
